Clinical Trial

Fentanyl Versus Midazolam as an Adjunct to Spinal Anesthesia

Study acronym: Spinal Block
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
It is well documented in the practice of anesthesia the effectiveness of bupivacaine when added with other adjuvants including midazolam, opioids, and ketamine during neuraxial spinal block for cesarean delivery, however comparison of the superiority of midazolam 2mg over fentanyl 25 micrograms or vice versa with bupivacaine during cesarean delivery has not been established and if performed diligently, could potentially change our understanding and current practice for better patient outcomes.
Trial Details
NCT Number NCT06917898
Lead Sponsor Makassed General Hospital
Conditions Healthy Female Volunteer
Enrollment 80 participants
Start Date 2025-04-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-09